Surgical Site Infections in Breast Surgery: The Use of Preoperative Antibiotics for Elective, Nonreconstructive Procedures

Figure 1

Surgical site infection rate by antibiotic and dose. Rates of SSI in nonreconstructive breast surgery patients were compared by antibiotic and dose. Clindamycin doses^∗ of 150 or 300 mg were combined as ≤300 mg and doses of 450 and 600 mg were combined as >300 mg. The 1-gram cefazolin dose was associated with significantly higher rates of SSI compared to no antibiotic prophylaxis, 13.2% versus 4.0%, . A ≤300 mg dose of clindamycin was also associated with significantly higher rates of SSI compared to no antibiotics, 15.4% versus 4.0%, .